Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.625
+0.115 (7.62%)
Mar 9, 2026, 3:43 PM EDT - Market open
Autolus Therapeutics Employees
As of December 31, 2024, Autolus Therapeutics had 650 total employees, including 647 full-time and 3 part-time employees. The number of employees increased by 179 or 38.00% compared to the previous year.
Employees
650
Change (1Y)
179
Growth (1Y)
38.00%
Revenue / Employee
$78,658
Profits / Employee
-$345,849
Market Cap
432.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sutro Biopharma | 178 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 104 |
| PepGen | 57 |
| PureTech Health | 56 |
| NovaBridge Biosciences | 32 |
| DiaMedica Therapeutics | 28 |
| Benitec Biopharma | 19 |
AUTL News
- 13 days ago - Autolus Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026 - GlobeNewsWire
- 2 months ago - Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform - Business Wire
- 2 months ago - Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform - GlobeNewsWire
- 3 months ago - Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025 - GlobeNewsWire
- 3 months ago - Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025 - GlobeNewsWire
- 3 months ago - Autolus Therapeutics Appoints Ryan Richardson to Board of Directors - GlobeNewsWire